| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 06/20/2000 | US6077518 Cloning of mite allergens |
| 06/15/2000 | WO2000034784A1 Protein scaffolds for antibody mimics and other binding proteins |
| 06/15/2000 | WO2000034483A2 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 06/15/2000 | WO2000034474A2 Growth factor homolog zvegf3 |
| 06/15/2000 | WO2000034452A1 Glucoamylases with n-terminal extensions |
| 06/15/2000 | WO2000034308A2 Protein transduction system and methods of use thereof |
| 06/15/2000 | WO2000034294A2 Tumor necrosis factor receptor homologue-1 ('trh1') |
| 06/15/2000 | WO2000033881A1 Biologically active conjugates having a detectable reporter moiety and method of identification of said derivative |
| 06/15/2000 | WO2000010598A3 Recombinant botulinium toxin for the treatment of mucus hypersecretion |
| 06/15/2000 | WO2000009693A3 Identification of the gene causing the mouse scurfy phenotype and its human ortholog |
| 06/15/2000 | WO2000006726A3 Delta-related polypeptides |
| 06/15/2000 | WO1999014328A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/15/2000 | CA2746535A1 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 06/15/2000 | CA2354868A1 Biologically active conjugates having a detectable reporter moiety and method of identification of said derivative |
| 06/15/2000 | CA2354612A1 Tumor necrosis factor receptor homologue-1 ("trh1") |
| 06/15/2000 | CA2354232A1 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 06/15/2000 | CA2354044A1 Protein transduction system and methods of use thereof |
| 06/15/2000 | CA2352046A1 Glucoamylases with n-terminal extensions |
| 06/15/2000 | CA2351346A1 Protein scaffolds for antibody mimics and other binding proteins |
| 06/14/2000 | EP1008355A1 Method for identifying or analyzing polymer linkage sites on macromolecules using amino acid report binding |
| 06/14/2000 | EP1007711A1 Für drosomycin kodierendes chimäres gen, dieses gen enhaltender vektor und herstellung von krankheitsresistenten transgenen pflanze |
| 06/14/2000 | EP1007696A1 Il-13 receptor specific chimeric proteins and uses thereof |
| 06/14/2000 | EP1007686A1 Tuberculosis vaccine |
| 06/14/2000 | EP1007666A1 Neurturin receptor |
| 06/14/2000 | EP1007653A1 Polypeptides comprising a coiled-coil and an addition site |
| 06/14/2000 | EP1007569A1 STIMULATION OF AN IMMUNE RESPONSE WITH ANTIBODIES LABELED WITH THE $g(a)-GALACTOSYL EPITOPE |
| 06/14/2000 | EP1007554A1 Oil bodies and associated proteins as affinity matrices |
| 06/14/2000 | EP1007551A2 Vaccine against hpv |
| 06/14/2000 | EP1007550A2 COMPOUNDS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF $i(EHRLICHIA) INFECTION |
| 06/14/2000 | EP1007535A1 Methods and compositions for diagnosis and treatment of breast cancer |
| 06/14/2000 | EP1007095A2 Chimeric toxins for targeted therapy |
| 06/14/2000 | EP1006797A1 Serpin enzyme complex receptor-mediated gene transfer |
| 06/14/2000 | EP1006782A1 Polypeptides fused with alfalfa mosaic virus or ilarvirus capsid |
| 06/13/2000 | US6075120 Bradykinin antagonist |
| 06/13/2000 | US6074639 Ex vivo expansion of hematopoietic cells using interleukin-3 (IL-3) variant fusion proteins |
| 06/13/2000 | CA2159079C Methods and dna expression systems for over-expression of proteins in host cells |
| 06/08/2000 | WO2000032823A1 Dna-protein fusions and uses thereof |
| 06/08/2000 | WO2000032794A2 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 06/08/2000 | WO2000032784A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 06/08/2000 | WO2000032778A2 Methods and compositions for inhibiting neoplastic cell growth |
| 06/08/2000 | WO2000032776A2 Secreted amd transmembrane polypeptides and nucleic acids encoding the same |
| 06/08/2000 | WO2000032773A1 Compositions and methods for increasing bone mineralization |
| 06/08/2000 | WO2000032625A1 Hbv core antigen particles with multiple immunogenic components attached via peptide ligands |
| 06/08/2000 | WO2000032221A2 Promotion or inhibition of angiogenesis and cardiovascularization |
| 06/08/2000 | WO2000015758A9 Plant resistance to insect pests mediated by viral proteins |
| 06/08/2000 | WO2000012536A3 Lipid matrix-assisted chemical ligation and synthesis of membrane polypeptides |
| 06/08/2000 | CA2503475A1 Promotion or inhibition of angiogenesis and cardiovascularization |
| 06/08/2000 | CA2353107A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 06/08/2000 | CA2352759A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 06/08/2000 | CA2352738A1 Hbv core antigen particles with multiple immunogenic components attached via peptide ligands |
| 06/08/2000 | CA2352532A1 Compositions and methods for increasing bone mineralization |
| 06/08/2000 | CA2348157A1 Methods and compositions for inhibiting neoplastic cell growth |
| 06/08/2000 | CA2347835A1 Promotion or inhibition of angiogenesis and cardiovascularization |
| 06/08/2000 | CA2347677A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/07/2000 | EP1005549A2 Prostate tumor polynucleotide and antigen compositions |
| 06/07/2000 | EP1005486A1 Inducible regulatory system and use thereof |
| 06/06/2000 | US6072049 Hepatitis B surface antigen vaccine |
| 06/06/2000 | US6072041 Single chain fv molecule directed against a transcytotic receptor covalently linked to a therapeutic protein; to deliver therapy to the other side of a cell |
| 06/06/2000 | US6072039 Hybrid polypeptide comparing a biotinylated avidin binding polypeptide fused to a polypeptide of interest |
| 06/06/2000 | US6071709 Nerve growth factor/receptor complex |
| 06/06/2000 | US6071522 Cloning of mite allergens |
| 06/06/2000 | CA1341018C Immunotoxins based on inactivated diphtheria toxins for cancer chemotherapy |
| 06/02/2000 | WO2000031278A1 Zace1: a human metalloenzyme |
| 06/02/2000 | WO2000031235A2 Nucleotide and protein sequences of nogo genes and methods based thereon |
| 06/02/2000 | WO2000031126A2 Suppression of xenotransplant rejection |
| 06/02/2000 | WO2000031124A2 Peptides that modulate the interaction of b class ephrins and pdz domains |
| 06/02/2000 | WO2000030667A2 Compositions and methods using lactadherin or variants thereof |
| 06/02/2000 | CA2352458A1 Compositions and methods using lactadherin or variants thereof |
| 06/02/2000 | CA2352083A1 Zace1: a human metalloenzyme |
| 06/02/2000 | CA2351893A1 Peptides that modulate the interaction of b class ephrins and pdz domains |
| 06/02/2000 | CA2350395A1 Nucleotide and protein sequences of nogo genes and methods based thereon |
| 06/02/2000 | CA2291453A1 Dna-constructs of blood clotting factors and p-selectin |
| 05/31/2000 | EP1004664A1 Compositions and methods using lactadherin or variants thereof |
| 05/31/2000 | EP1003888A2 Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis |
| 05/31/2000 | EP1003879A1 Antigen constructs useful in the detection and differentiation of antibodies to hiv |
| 05/31/2000 | EP1003861A2 Mammalian cell membrane proteins; related reagents |
| 05/31/2000 | EP1003856A1 Apaf-1, the ced-4 human homolog, an activator of caspase-3 |
| 05/31/2000 | EP1003851A2 Syncytial respiratory virus epitopes and antibodies comprising them, useful in diagnosis and therapy |
| 05/31/2000 | EP1003840A1 Synthetic genes for plant gums |
| 05/31/2000 | EP1003781A1 Interleukin-18 binding proteins, their preparation and use |
| 05/31/2000 | EP1003777A1 PGC-1, A NOVEL BROWN FAT PPAR$g(g) COACTIVATOR |
| 05/31/2000 | EP0791013B1 Methods and compositions for screening for presynaptic calcium channel blockers |
| 05/30/2000 | US6069301 Antibodies which bind to insect gut proteins and their use |
| 05/30/2000 | US6069230 High level expression and facile purification of proteins, peptides and conjugates for immunization, purification and detection applications |
| 05/30/2000 | US6068992 Production of gonorrheal PI proteins and vaccines |
| 05/30/2000 | US6068841 Antibodies to Fas-L for treatment of hepatitis |
| 05/30/2000 | CA2045200C Immobilization of biomolecules by enhanced electophoretic precipitation |
| 05/25/2000 | WO2000029588A1 Lysozyme fusion proteins in infections |
| 05/25/2000 | WO2000029577A1 Novel members of the capsaicin/vanilloid receptor family of proteins and uses thereof |
| 05/25/2000 | WO2000029438A1 Egf-like nucleic acids and polypeptides and uses thereof |
| 05/25/2000 | WO2000029428A2 5t4 tumour-associated antigen for use in tumour immunotherapy |
| 05/25/2000 | WO2000008443A9 Multiple frequency fluorescence lifetime imaging |
| 05/25/2000 | DE19853807A1 New covalently linked protein complex, useful particularly as stabilized form of DNA polymerase, produced by heating lyophilized protein under vacuum |
| 05/25/2000 | CA2351622A1 Polypeptide |
| 05/25/2000 | CA2351522A1 Egf-like nucleic acids and polypeptides and uses thereof |
| 05/25/2000 | CA2349837A1 Lysozyme fusion proteins in infections |
| 05/25/2000 | CA2348479A1 Novel members of the capsaicin/vanilloid receptor family of proteins and uses thereof |
| 05/24/2000 | EP1002861A1 Antigen-binding proteins comprising a linker which confers restricted conformational flexibility |
| 05/24/2000 | EP1002112A1 Agent for expressing and detecting a fusion polypeptide with an hpol-epitope and a polypeptide |
| 05/24/2000 | EP1002110A1 Immune responses against hpv antigens elicited by compositions comprising an hpv antigen and a stress protein or an expression vector capable of expression of these proteins |